Curasept Afterapid

CURASEPT SpA · Quelle

MOUTH ULCERS: A TROUBLESOME ISSUE

Aphthous ulcers are the most common lesions of the oral mucosa, and in 80% of cases the first aphthous ulcer appears before the age of 30. The prevalence of this problem can affect up to 60% of the population. It is estimated that in one-fifth of cases, episodes are frequent and repeated over the years.

PREDISPOSING FACTORS

  • Nutritional deficiencies
  • Systemic diseases
  • Psychological conditions
  • Mucosal injuries
  • Genetic predisposition
  • Allergies and intolerances

THE SYMPTOMS

  • Spontaneous pain and burning at phonation.
  • Swelling and pain in nearby lymph nodes.
  • Increased salivation.
  • Difficulty and pain in chewing with possible loss of appetite.
  • Difficulty and pain with oral hygiene maneuvers.
  • Diagnosis is mainly based on clinical appearance and medical history.

THE AFTERAPID FORMULATION

It's a comprehensive and innovative formulation based on the emulsion of MUCOADESIVE POLYMERS ENRICHED WITH ACTIVE PARTICLES that protect the wound, provide relief and accelerate healing.

DNA/RNA

STIMULATES BIOLOGICAL MECHANISMS OF TISSUE REPAIR

BIOMOIST® HYALURONIC ACID

FILM-FORMING AND MOISTURIZING POWER

TEA TREE OIL AND MANUKA OIL

ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY

18ß GLYCIRRETIC ACID

ANTI-INFLAMMATORY FUNCTION

RUSCOGENIN

ASTRINGENT ACTIVITY

ALLANTOIN

CELL PROLIFERATION

QUICK RELIEF, QUICK RECOVERY

Forms a lipid-protective film on the wound.

Produktinformationen

HerstellerCURASEPT SpA